Trial Profile
Efficacy and safety of Filgotinib plus background Methotrexate on the markers of inflammation in patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2017
Price :
$35
*
At a glance
- Drugs Filgotinib (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 05 Jul 2017 New trial record
- 17 Jun 2017 Results assessing the effect of filgotinib on multi-biomarker disease activity (MBDA) score, presented at the 18th Annual Congress of the European League Against Rheumatism
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism